Dingal, Pedro .
HRN: 02-99-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2024
METRONIDAZOLE 500MG (TAB)
09/09/2024
09/18/2024
PO
500 Mg/tab, 1 Tab
TID
H. Pylori Infection;
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes